Century Therapeutics, Inc. (IPSC)
NASDAQ: IPSC · Real-Time Price · USD
0.5029
-0.0074 (-1.45%)
At close: Sep 9, 2025, 4:00 PM
0.5027
-0.0002 (-0.04%)
After-hours: Sep 9, 2025, 7:21 PM EDT
Century Therapeutics Market Cap
Century Therapeutics has a market cap or net worth of $43.45 million as of September 9, 2025. Its market cap has decreased by -71.35% in one year.
Market Cap
43.45M
Enterprise Value
-60.91M
1-Year Change
-71.35%
Ranking
Category
Stock Price
$0.50
Market Cap Chart
Since the IPO on June 18, 2021, Century Therapeutics's market cap has decreased from $1.05B to $43.45M, a decrease of -95.87%. That is a compound annual growth rate of -52.94%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Sep 8, 2025 | 44.08M | -48.67% |
| Dec 31, 2024 | 85.88M | -56.77% |
| Dec 29, 2023 | 198.65M | -34.34% |
| Dec 30, 2022 | 302.54M | -65.09% |
| Dec 31, 2021 | 866.61M | -17.54% |
| Jun 18, 2021 | 1.05B | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 663.10B |
| Johnson & Johnson | 429.00B |
| AbbVie | 370.61B |
| UnitedHealth Group | 290.04B |
| AstraZeneca | 251.37B |
| Novartis AG | 249.66B |
| Novo Nordisk | 242.52B |
| Abbott Laboratories | 230.09B |